BioLineRx Ltd. - Director Stock Option Grants

This filing details stock option grants to Rami Dar, a director at BioLineRx Ltd. The grants were made under the 2003 Amended and Restated Share Incentive Plan. Several option grants have exercise dates in 2022, 2023, and 2024, with corresponding expiration dates in 2032 and 2033. One grant with an exercise date of October 1, 2024, has a portion vested immediately and the remainder vesting in quarterly installments. Another grant, dated October 1, 2024, has a portion vested immediately upon appointment, with the rest vesting over seven quarters. All options are exercisable for Ordinary Shares of BioLineRx Ltd. The filing indicates these options are directly held by the reporting owner.